A Fasolo
Overview
Explore the profile of A Fasolo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
1083
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grilley-Olson J, Bedard P, Fasolo A, Cornfeld M, Cartee L, Razak A, et al.
Invest New Drugs
. 2016 Jul;
34(6):740-749.
PMID: 27450049
Introduction This Phase Ib trial investigated the safety, tolerability, and recommended phase 2 dose for the pan-PI3K/mTOR inhibitor, GSK2126458 (GSK458), and trametinib combination when administered to patients with advanced solid...
2.
Frigo A, Fasolo A, Capuzzo C, Fornea M, Bellucci R, Busin M, et al.
Transplant Proc
. 2015 Mar;
47(2):528-35.
PMID: 25769602
This study aims to examine evolving indications and changing trends for corneal transplantation in Italy. Corneal transplantations performed with donor tissues distributed by the Veneto Eye Bank Foundation between 2002...
3.
Joerger M, Hess D, Delmonte A, Gallerani E, Fasolo A, Gianni L, et al.
Br J Clin Pharmacol
. 2015 Jan;
80(1):128-38.
PMID: 25580946
Aims: Namitecan is a new camptothecan compound undergoing early clinical development. This study was initiated to build an integrated pharmacokinetic (PK) and pharmacodynamic (PD) population model of namitecan to guide...
4.
Del Conte G, Sessa C, von Moos R, Vigano L, Digena T, Locatelli A, et al.
Br J Cancer
. 2014 Jul;
111(4):651-9.
PMID: 25025963
Background: Olaparib, an oral PARP inhibitor, has shown antitumour activity as monotherapy in patients with germline BRCA1/2 (gBRCA)-mutated breast and ovarian cancer. This study evaluated olaparib capsules in combination with...
5.
Fasolo A, Sessa C, Gianni L, Broggini M
Ann Oncol
. 2012 Nov;
24(1):14-20.
PMID: 23110808
MET is a tyrosine kinase receptor for hepatocyte growth factor (HGF), primarily expressed on epithelial cells; the activation of MET induces several biological responses relevant for the development and growth...
6.
Gribaudo S, Bovetti S, Friard O, Denorme M, Oboti L, Fasolo A, et al.
J Comp Neurol
. 2012 May;
520(14):3055-69.
PMID: 22592880
Neurogranin (Ng) is a brain-specific postsynaptic calmodulin-binding protein involved in synaptic activity-dependent plasticity. In the adult olfactory bulb (OB), Ng is expressed by a large population of GABAergic interneurons in...
7.
Oboti L, Peretto P, De Marchis S, Fasolo A
Eur J Histochem
. 2012 Feb;
55(4):e35.
PMID: 22297441
The olfactory system is the appropriate model for studying several aspects of neuronal physiology spanning from the developmental stage to neural network remodelling in the adult brain. Both the morphological...
8.
Gribaudo S, Bovetti S, Garzotto D, Fasolo A, De Marchis S
J Comp Neurol
. 2009 Oct;
517(5):683-94.
PMID: 19827160
Neurogranin (Ng) is a brain-specific postsynaptic protein involved in activity-dependent synaptic plasticity through modulation of Ca(2+)/calmodulin (CaM)-dependent signal transduction in neurons. In this study, using biochemical and immunohistochemical approaches, we...
9.
Oboti L, Savalli G, Giachino C, De Marchis S, Panzica G, Fasolo A, et al.
Eur J Neurosci
. 2009 Feb;
29(4):679-92.
PMID: 19200078
Newborn neurons generated by proliferative progenitors in the adult subventricular zone (SVZ) integrate into the olfactory bulb circuitry of mammals. Survival of these newly-formed cells is regulated by the olfactory...
10.
Perotti A, Sessa C, Mancuso A, Noberasco C, Cresta S, Locatelli A, et al.
Ann Oncol
. 2009 Feb;
20(4):741-5.
PMID: 19190075
Background: Upregulation of N-cadherin promotes dysregulated cell growth, motility, invasiveness, plus maintenance of vascular stability and is associated with cancer progression in several human tumour types. N-cadherin is expressed also...